Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0050
+0.0020 (66.67%)
At close: Oct 3, 2025
66.67%
Market Cap172.40K
Revenue (ttm)n/a
Net Income (ttm)-11.62M
Shares Out34.48M
EPS (ttm)-0.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume50,014
Average Volume197,814
Open0.0050
Previous Close0.0030
Day's Range0.0050 - 0.0050
52-Week Range0.0001 - 0.0080
Beta3.51
RSI63.92
Earnings Daten/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.